查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553527

移植诊断的全球市场规模、份额和趋势分析：按测试、产品、应用、移植部位、最终用途、地区和细分市场进行预测（2024-2030）

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Assays, Non-Molecular Assays), By Product, By Application, By Transplant Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

移植诊断市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球移植诊断市场规模将达到97.4亿美元，2024年至2030年复合年增长率为7.3%。由于患有经常导致器官衰竭的慢性疾病的患者数量不断增加，对移植手术的需求正在迅速增加。此外，干细胞疗法和个人化医疗的日益普及正在影响移植诊断的需求。

与器官移植相关的风险和复杂性需要改进和先进的诊断工具。由于对高通量诊断工具的需求不断增加，次世代定序（NGS）技术正迅速取代传统的诊断方法，例如用于人类白血球抗原（HLA）分型的血清学方法。

市场成长预计将受到世界某些地区报销争议和道德问题等因素的限制。此外，使用聚合酵素链锁反应(PCR) 和 NGS 仪器进行 HLA 匹配的高成本正在影响新兴国家移植诊断市场的成长。

移植诊断市场报告亮点

  • 预计从 2024 年到 2030 年，基于序列的打字领域将显着成长。 NGS 的高采用率是该细分市场成长的主要驱动力。
  • 由于其成熟的研究基础设施、不断增长的医疗支出、先进诊断技术的广泛采用以及研发活动的活性化，预计北美将在 2023 年占据最大的收益占有率，并在整个预测期内保持主导地位。
  • 由于研究机会、医疗保健支出、医疗旅游业和器官捐赠意识的不断扩大，亚太地区预计将在预测期内显着增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章移植诊断市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 移植诊断市场分析工具
    • 波特的分析
    • PESTEL分析

第四章移植诊断市场：测试估计和趋势分析

  • 细分仪表板
  • 移植诊断市场：测试分析（2023/2030）
  • 分子测定
  • 基于定序的分子测定
  • 非分子测定

第五章 移植诊断市场：产品估算与趋势分析

  • 细分仪表板
  • 移植诊断市场：产品分析（2023/2030）
  • 试剂/耗材
  • 装置
  • 软体和服务

第六章 移植诊断市场：使用量估算与趋势分析

  • 细分仪表板
  • 移植诊断市场：应用分析（2023/2030）
  • 诊断用途
    • 传染病检查
    • 组织相容性试验
    • 血液分析
  • 研究用途

第七章 移植诊断市场：移植部位估算及趋势分析

  • 细分仪表板
  • 移植诊断市场：移植部位分析（2023/2030）
  • 固态器官移植
  • 干细胞移植
  • 软组织移植
  • 骨髓移植

第八章移植诊断市场：最终用途估计与趋势分析

  • 细分仪表板
  • 移植诊断市场：最终用途分析（2023/2030）
  • 医院/移植中心
  • 研究/学术机构
  • 独立参考实验室

第九章移植诊断市场：区域估计与趋势分析

  • 移植诊断市场占有率：依地区划分（2023/2030）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • F. Hoffmann La-Roche Ltd
    • Abbott
    • QIAGEN
    • Bruker
    • BD（Becton, Dickinson and Company）
    • Werfen（Immucor, Inc.）
    • Bio-Rad Laboratories, Inc.
    • Omixon Inc.
简介目录
Product Code: 978-1-68038-970-8

Transplant Diagnostics Market Growth & Trends:

The global transplant diagnostics market size is expected to reach USD 9.74 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Transplant Diagnostics Market Report Highlights:

  • The sequencing-based typing segment is anticipated to witness significant growth from 2024 to 2030. High adoption of NGS is a major factor driving segment growth
  • North America captured the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
  • Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, the medical tourism industry, and awareness regarding organ donation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transplant Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transplant Diagnostics: Test Outlook Analysis, USD Million, 2023 & 2030
  • 4.3. Molecular Assays
    • 4.3.1. PCR-based Molecular Assays
      • 4.3.1.1. PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Real-Time PCR
      • 4.3.2.1. Real-Time PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Sequence-based Primer-PCR
      • 4.3.3.1. Sequence-based Primer-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Sequence-specific Oligonucleotide-PCR
      • 4.3.4.1. Sequence-specific Oligonucleotide-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Other PCR-based Molecular Assays
      • 4.3.5.1. Other PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Sequencing-based Molecular Assays
    • 4.4.1. Sanger Sequencing
      • 4.4.1.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Next Generation Sequencing
      • 4.4.2.1. Next Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Other Sequencing-based Molecular Assays
      • 4.4.3.1. Other Sequencing-based Molecular Assays Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Non-molecular Assays
    • 4.5.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.1. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transplant Diagnostics Market: Product Analysis, USD Million, 2023 & 2030
  • 5.3. Reagents & Consumables
    • 5.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Software and Services
    • 5.5.1. Software and Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transplant Diagnostics Market: Application Analysis, USD Million, 2023 & 2030
  • 6.3. Diagnostics Application
    • 6.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Infectious Disease Testing
      • 6.3.2.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Histocompatibility Testing
      • 6.3.3.1. Histocompatibility Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Blood Profiling
      • 6.3.4.1. Blood Profiling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Research Application
    • 6.4.1. Research Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transplant Diagnostics Market: Transplant Area Analysis, USD Million, 2023 & 2030
  • 7.3. Solid Organ Transplantation
    • 7.3.1. Kidney Transplantation
      • 7.3.1.1. Kidney Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Liver Transplantation
      • 7.3.2.1. Liver Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Heart Transplantation
      • 7.3.3.1. Heart Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Lungs Transplantation
      • 7.3.4.1. Lungs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Pancreas Transplantation
      • 7.3.5.1. Pancreas Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Other Organs Transplantation
      • 7.3.6.1. Other Organs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Stem Cell Transplantation
    • 7.4.1. Stem Cell Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Soft Tissue Transplantation
    • 7.5.1. Soft Tissue Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Bone Marrow Transplantation
    • 7.6.1. Bone Marrow Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Transplant Diagnostics Market: End Use Analysis, USD Million, 2023 & 2030
  • 8.3. Hospitals and Transplant Centers
    • 8.3.1. Hospitals and Transplant Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Research and Academic Institutes
    • 8.4.1. Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Independent Reference Laboratories
    • 8.5.1. Independent Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Transplant Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Transplant Diagnostics Market Share, By Region, 2023 & 2030, USD Million
  • 9.2. North America
    • 9.2.1. North America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.K.
      • 9.3.2.1. U.K. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. China Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Australia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. South Korea Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Saudi Arabia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. UAE Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Recent Developments/ Strategic Initiatives
    • 10.4.2. Illumina, Inc.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Recent Developments/ Strategic Initiatives
    • 10.4.3. F. Hoffmann La-Roche Ltd
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Recent Developments/ Strategic Initiatives
    • 10.4.4. Abbott
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Recent Developments/ Strategic Initiatives
    • 10.4.5. QIAGEN
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Bruker
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Recent Developments/ Strategic Initiatives
    • 10.4.7. BD (Becton, Dickinson and Company)
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Recent Developments/ Strategic Initiatives
    • 10.4.8. Werfen (Immucor, Inc.)
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Recent Developments/ Strategic Initiatives
    • 10.4.9. Bio-Rad Laboratories, Inc.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Recent Developments/ Strategic Initiatives
    • 10.4.10. Omixon Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Recent Developments/ Strategic Initiatives